祥生医疗: 无锡祥生医疗科技股份有限公司章程

Core Points - The company is Wuxi Chison Medical Technologies Co., Ltd., established in accordance with the Company Law of the People's Republic of China and other relevant regulations [5][6] - The company was registered with the China Securities Regulatory Commission (CSRC) on October 28, 2019, and publicly issued 20 million ordinary shares, listing on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 3, 2019 [5][6] - The registered capital of the company is RMB 112,124,537.00 [5] - The company's business scope includes research, development, manufacturing, sales, and maintenance of medical devices, software development, and import-export of various goods and technologies [5][6] Company Structure - The company operates as a permanent joint-stock company with a governance structure that includes a chairman who also serves as the legal representative [5][6] - Shareholders are liable for the company's debts only to the extent of their subscribed shares, while the company is liable for its debts with all its assets [6] - The company has established a Communist Party organization to conduct activities in accordance with the Party's regulations [6] Share Issuance and Management - The company issues shares in a manner that ensures equal rights for all shares of the same category, with a nominal value of RMB 1 per share [7][9] - The total number of shares issued by the company is 112,124,537, all of which are ordinary shares [9] - The company may not provide financial assistance for others to acquire its shares, except for employee stock ownership plans [9][10] Shareholder Rights and Responsibilities - Shareholders have the right to receive dividends and participate in shareholder meetings, where they can exercise voting rights [17][19] - Shareholders are obligated to comply with laws and regulations, pay for their subscribed shares, and not misuse their rights to harm the company or other shareholders [22][43] - The company must disclose information regarding significant transactions and ensure that shareholder meetings are conducted in compliance with legal requirements [19][30]